CoChat

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

Open access
Ferguson, Ian D., Patiño-Escobar, Bonell, Tuomivaara, Sami T., Lin, Yu-Hsiu T., Nix, Matthew A., Leung, Kevin K., Kasap, Corynn, Ramos, Emilio, Nieves Vasquez, Wilson, Talbot, Alexis, Hale, Martina, Naik, Akul, Kishishita, Audrey, Choudhry, Priya, Lopez-Girona, Antonia, Miao, Weili, Wong, Sandy W., Wolf, Jeffrey L., Martin, Thomas G., Shah, Nina, Vandenberg, Scott, Prakash, Sonam, Besse, Lenka, Driessen, Christoph, Posey, Avery D., Mullins, R. Dyche, Eyquem, Justin, Wells, James A., Wiita, Arun P. · 2022 · Nature Communications
Cited by 118

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The myeloma surface proteome (surfaceome) determines tumor interaction with the microenvironment and serves as an emerging arena for therapeutic development. Here, we use glycoprotein capture proteomics to define the myeloma surfaceome at baseline, in drug resistance, and in response to acute drug treatment. We provide a scoring system for surface antigens and identify CCR10 as a promising target in this disease expressed widely on malignant plasma cells. We engineer proof-of-principle chimeric antigen receptor (CAR) T-cells targeting CCR10 using its natural ligand CCL27. In myeloma models we identify proteins that could serve as markers of resistance to bortezomib and lenalidomide, including CD53, CD10, EVI2B, and CD33. We find that acute lenalidomide treatment increases activity of MUC1-targeting CAR-T cells through antigen upregulation. Finally, we develop a miniaturized surface proteomic protocol for profiling primary plasma cell samples with low inputs. These approaches and datasets may contribute to the biological, therapeutic, and diagnostic understanding of myeloma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-31810-6

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 118

Metadata

Authors
Ferguson, I. D., Patiño-Escobar, B., Tuomivaara, S. T., Lin, Y.-H. T., Nix, M. A., Leung, K. K., Kasap, C., Ramos, E., Nieves Vasquez, W., Talbot, A., Hale, M., Naik, A., Kishishita, A., Choudhry, P., Lopez-Girona, A., Miao, W., Wong, S. W., Wolf, J. L., Martin, T. G., Shah, N., Vandenberg, S., Prakash, S., Besse, L., Driessen, C., Posey, A. D., Mullins, R. D., Eyquem, J., Wells, J. A., & Wiita, A. P.
Venue
Nature Communications
Published
2022-07-15
Volume
13
Issue
1
Pages
4121-4121
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4285493547
Cited by
118
References
16
FWCI
16.39
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. https://app.cochat.ai/papers/10.1038/s41467-022-31810-6
The paper
Ferguson, I. D., Patiño-Escobar, B., Tuomivaara, S. T., Lin, Y.-H. T., Nix, M. A., Leung, K. K., Kasap, C., Ramos, E., Nieves Vasquez, W., Talbot, A., Hale, M., Naik, A., Kishishita, A., Choudhry, P., Lopez-Girona, A., Miao, W., Wong, S. W., Wolf, J. L., Martin, T. G., . . . Wiita, A. P. (2022). The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature Communications. https://doi.org/10.1038/s41467-022-31810-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.